Inclusion complex improves solubility of andrographolide, indicating enhanced drug delivery in oral applications.
A significant increase in solubility of andrographolide (AND), a slightly water soluble anti-inflammatory and antimicrobial drug, was achieved by inclusion with hydroxypropyl-β-cyclodextrin (HP-β-CD). The inclusion complex was prepared by solvent evaporation and characterized by the phase solubility method, X-ray diffractometry and differential scanning calorimetry. The solubility of AND increased linearly as a function of HP-β-CD concentration, resulting in AL-type phase solubility diagram. Molecular modeling calculations were used to foresee the possible orientations of AND inside the HP-β-CD cavity. The in vitro dissolution profile showed a significant increase in dissolving rate and percent of the inclusion complex compared with uncomplexed drug. In vivo pharmacokinetic study showed that AUC0–∞ was 1.6-fold higher than that of AND suspension after oral administration. These results suggest that HP-β-CD inclusion system might be a promising formulation for the oral delivery of AND.
No takes yet. Share an insight, caveat, or question.
Ren et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: